TLRYTilray Brands, Inc.
Price
-79%1YEnd-of-day closes, not the intraday tick.
Mostly good, one thing to check: the market
Quality strong, nothing alarming, growing in the filings, the market against it.
Charts
As reported to the SEC, without any scoring.
Tilray Brands, Inc. (TLRY) reported revenue of $257M in Q1 2027 (quarter ended Aug 31, 2026), up 23% from the same quarter a year earlier. That came with a gross margin of 30% and net loss of $43M. For the full year FY2026, revenue was $915M (+11% year on year) and net income −$121M. The next results filing is expected around Jan 7, 2027, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 8, 2026Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution.Earnings release · press release
- Sep 14, 2026Between August 31, 2026 and September 8, 2026, Tilray Brands, Inc. (the “Company”) entered into certain private debt-for-equity exchange transactions (the “Exchange Transactions”) with unrelated parties.Unregistered sale of equity · Form 8-K
- Aug 10, 2026On August 4, 2026, Tilray Brands, Inc. (the “Company”) entered into certain private debt-for-equity exchange transactions (the “Exchange Transactions”) with unrelated parties.Unregistered sale of equity · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Drug Manufacturers, Specialty & Generic
Ranks #32 of 41 by RyuScore